全文获取类型
收费全文 | 676篇 |
免费 | 2篇 |
国内免费 | 4篇 |
专业分类
安全科学 | 9篇 |
环保管理 | 4篇 |
综合类 | 651篇 |
基础理论 | 8篇 |
污染及防治 | 3篇 |
评价与监测 | 2篇 |
社会与环境 | 3篇 |
灾害及防治 | 2篇 |
出版年
2021年 | 6篇 |
2020年 | 1篇 |
2018年 | 2篇 |
2017年 | 3篇 |
2016年 | 2篇 |
2013年 | 4篇 |
2012年 | 5篇 |
2011年 | 34篇 |
2010年 | 35篇 |
2009年 | 34篇 |
2008年 | 28篇 |
2007年 | 38篇 |
2006年 | 40篇 |
2005年 | 55篇 |
2004年 | 44篇 |
2003年 | 43篇 |
2002年 | 59篇 |
2001年 | 28篇 |
2000年 | 1篇 |
1999年 | 2篇 |
1996年 | 1篇 |
1995年 | 27篇 |
1994年 | 44篇 |
1993年 | 22篇 |
1992年 | 14篇 |
1991年 | 25篇 |
1990年 | 12篇 |
1989年 | 12篇 |
1988年 | 15篇 |
1987年 | 11篇 |
1986年 | 4篇 |
1985年 | 11篇 |
1984年 | 11篇 |
1983年 | 3篇 |
1982年 | 2篇 |
1981年 | 4篇 |
排序方式: 共有682条查询结果,搜索用时 296 毫秒
501.
502.
503.
A new case of mosaic tetrasomy 12 p (46, XY/47, XY, + i 12 p), diagnosed during pregnancy from ultrasonographic signs, is reported. We emphasize the peculiar position of the diaphragmatic hernia in this syndrome. Its presence or absence determines the vital prognosis and the age of diagnosis. The knowledge of its possible association with tetrasomy 12 p can contribute considerably to the neonatal diagnosis by directing the work of the cytogeneticist to tissue cultures which enable him to detect the presence of the tetrasomy. 相似文献
504.
Howard Cuckle 《黑龙江环境通报》1995,15(11):1057-1065
A new method is described for calculating maternal serum marker distribution parameters which will improve risk estimation when screening for Down's syndrome. The approach is to calculate parameters using data from the local screened population and data obtained by meta-analysis from all published studies. The local data are used to derive the variance and covariance in unaffected pregnancies. The meta-analysis is used for the mean level in Down's syndrome pregnancies together with the differences in variance and covariance between affected and unaffected pregnancies. Forty-four published studies were analysed. The mean level for Down's syndrome in multiples of the normal median was 0·73 for alpha-fetoprotein (AFP) in total of 1140 pregnancies, 0·73 for unconjugated oestriol (uE3) in 613, 2·02 for human chorionic gonadotropin (hCG) in 850, and 2·30 for free β-hCG in 477. For all four markers, the variance in Down's syndrome was higher than in unaffected pregnancies; for AFP and uE3, the covariances were also higher in Down's syndrome, but for the other markers they were lower. The method was illustrated using data from 6387 pregnancies screened in Leeds. 相似文献
505.
L. Sentilhes E. Verspyck D. Eurin V. Ickowicz S. Patrier J. Lechevallier L. Marpeau 《黑龙江环境通报》2004,24(3):198-201
Amniotic band syndrome or amniotic disruption complex is a well-known congenital limb abnormality, which occurs in 1 in 1200 to 1 in 15 000 live births. In cases of an isolated band constriction, it has been speculated that the bands lead to decreased blood flow in the constricted limb and subsequent natural amputation. Fetal surgery could be considered in these situations in order to release the constriction band in threatened limb amputation. We present a case of a tight constriction ring secondary to amniotic band syndrome with a favourable outcome, despite the failure of an attempted surgical procedure. Copyright © 2004 John Wiley & Sons, Ltd. 相似文献
506.
507.
508.
Françoise Muller Sophie Dreux Jean-François Oury Dominique Luton Serge Uzan Michèle Uzan Michel Levardon Marc Dommergues 《黑龙江环境通报》2002,22(11):1001-1004
Women having access to prenatal care late in pregnancy may still wish to benefit from maternal serum screening for Down syndrome. Therefore, we established reference values for α-feto protein (AFP) and free β-human chorionic gonadotrophin (β-hCG), and assessed the diagnostic value of maternal serum marker screening at 18–35 weeks' gestation based upon a series of 4072 sera from unaffected pregnancies and 118 sera from pregnant women with fetuses affected by Down syndrome. Using a 1/250 risk cut-off, a detection rate of 72.9% (95% CI = 71.5–74.3%) was achieved with a false-positive rate of 7.51% (95% CI = 6.71–8.3%). This was not significantly different from the percentages observed in our 14–17 weeks routine screening (50 596 patients): 71.9% (95% CI = 71.5–72.3%) and 6.48% (95% CI = 6.28–6.68%), respectively. Detection and screen-positive rates were, respectively, 51.3% (95% CI = 35.6–67.0%) and 5.95% (95% CI = 5.12–6.68%) in women aunder 35 years of age, and 84.8% (95% CI = 76.9–92.7%) and 24% (95% CI = 20.7–27.3%) in women aged 35 years and over. In conclusion, maternal serum marker screening is feasible at 18 weeks' gestation and later, which may be of interest in selected cases. Copyright © 2002 John Wiley & Sons, Ltd. 相似文献
509.
提出和采用树干输液方法提高大树移栽成活率.该方法具有简便、实用、操作容易、能显著提高移栽成活率等优点,介绍了树干输液方法、输液时期和输液剂量以及营养液的研制等内容. 相似文献
510.
Professor Jacob A. Canick Ph.D. Leonard H. Kellner Devereux N. Saller Jr Glenn E. Palomaki Roger P. Walker Rapin Osathanondh 《黑龙江环境通报》1995,15(8):739-744
Urinary gonadotropin peptide (UGP; β-core fragment), a major metabolite of human chorionic gonadotropin (hCG), was shown recently to be markedly elevated in Down syndrome pregnancy between 19 and 22 weeks of gestation. To confirm and extend this finding, we obtained maternal urine and matching maternal serum samples from 14 cases of Down syndrome and six other aneuploidies between 17 and 21 weeks of gestation. UGP was measured in all these samples and in 91 singleton control urines. Results were corrected for urinary creatinine level and expressed as multiples of the control median (MOM). hCG levels were assayed in all serum samples from the cases and compared with previously established reference values. The median UGP level in Down syndrome cases was 5.34 MOM (range 2.71–12.57); 88 per cent of the values were above the 95th centile of control levels after modelling. The median maternal serum hCG level for the same cases was 2.20 MOM (range 0.84–3.40); 36 per cent of the values were above the 95th centile. The level of UGP in every case including all other aneuploidies was higher than the comparable maternal serum hCG level. Elevated UGP measurements are strongly associated with fetal Down syndrome during the second trimester and could contribute to improved Down syndrome screening protocols that are more accessible and less expensive than are currently available. 相似文献